Merck and Ridgeback Say Covid-19 Pill Effective against Omicron

Seeking Alpha2022-01-28

Merck(NYSE:MRK)and Ridgeback Biotherapeutics, its partner in the development of the FDA-authorized COVID-19 therapy, molnupiravir announced that the oral medication was found to be effective against ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Ahleepapa
2022-01-28
Ahleepapa
SHORT
brendas
2022-01-28
brendas
Stonk

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1134543245?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-01-28 20:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134543245","market":"us","top_or_hot":-1,"title":"Merck and Ridgeback Say Covid-19 Pill Effective against Omicron","media":"Seeking Alpha","content":"<div>\n<p>Merck(NYSE:MRK)and Ridgeback Biotherapeutics, its partner in the development of the FDA-authorized COVID-19 therapy, molnupiravir announced that the oral medication was found to be effective against ...</p>\n\n<a href=\"https://seekingalpha.com/news/3792953-merck-ridgeback-say-covid-19-pill-effective-against-omicron\">Source Link</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck and Ridgeback Say Covid-19 Pill Effective against Omicron</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck and Ridgeback Say Covid-19 Pill Effective against Omicron\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-28 20:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3792953-merck-ridgeback-say-covid-19-pill-effective-against-omicron><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck(NYSE:MRK)and Ridgeback Biotherapeutics, its partner in the development of the FDA-authorized COVID-19 therapy, molnupiravir announced that the oral medication was found to be effective against ...</p>\n\n<a href=\"https://seekingalpha.com/news/3792953-merck-ridgeback-say-covid-19-pill-effective-against-omicron\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRK","symbol_name":"默沙东","start_time":0,"source_url":"https://seekingalpha.com/news/3792953-merck-ridgeback-say-covid-19-pill-effective-against-omicron","article_id":"1134543245","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134543245","pubTimestamp":1643371540,"sourceInfo":null,"weMediaInfo":null,"summary":"Merck(NYSE:MRK)and Ridgeback Biotherapeutics, its partner in the development of the FDA-authorized C","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRK":"默沙东"},"translate_title":"默克和里奇巴克称新冠肺炎药丸对奥密克戎有效","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRK":0.9},"content_text":"Merck(NYSE:MRK)and Ridgeback Biotherapeutics, its partner in the development of the FDA-authorized COVID-19 therapy, molnupiravir announced that the oral medication was found to be effective against Omicron variant across six pre-clinical studies.The in vitro studies were performed by investigators in six countries including the U.S. and Germany. The researchers had based their conclusions on established cell-based assays that assessed the impact of molnupiravir and other COVID-19 antiviral agents against SARS-CoV-2 variants of concern including Omicron.However, molnupiravir has yet to undergo clinical studies to evaluate its effect against Omicron, Merck (MRK) and Ridgeback, added.Merck (MRK) and Ridgeback Biotherapeutics have previously said that molnupiravir cut the risk of hospitalization or death by about 30% in a Phase 3 trial involving patients with mild-to-moderate COVID-19.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9099251838,"gmtCreate":1643373235945,"gmtModify":1676533812383,"author":{"id":"3585038405943602","authorId":"3585038405943602","name":"Ahleepapa","avatar":"https://static.tigerbbs.com/dcc1fea9c38112b58c68a2d96017330b","vip":1,"crmLevel":1,"crmLevelSwitch":1,"idStr":"3585038405943602","authorIdStr":"3585038405943602"},"htmlText":"SHORT","listText":"SHORT","text":"SHORT","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099251838","repostId":1134543245,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9099225493,"gmtCreate":1643372206838,"gmtModify":1676533812273,"author":{"id":"3571203337444590","authorId":"3571203337444590","name":"brendas","avatar":"https://static.tigerbbs.com/e2ed46705e008f65e490dea9dcfd40fb","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3571203337444590","authorIdStr":"3571203337444590"},"htmlText":"Stonk","listText":"Stonk","text":"Stonk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099225493","repostId":1134543245,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":32,"commentSize":2,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1134543245"}